Mealey's ( October 16, 2024, 8:56 AM EDT) -- YAKIMA, Wash. — Washington and other states that sued the U.S. Food and Drug Administration over the agency’s decision to add Risk Evaluation and Mitigation Strategy (REMS) restriction on mifepristone, one of the two drugs prescribed for medication abortions, say summary judgment is warranted now that the case has restarted after being placed on hold awaiting the U.S. Supreme Court’s decision in a related mifepristone case....